Exyte Builds mRNA Competence Center for WACKER in Germany
A messenger ribonucleic acid (mRNA) competence center is being built at the Halle Biotech site of German company Wacker Chemie AG (WACKER).
Source: labiotech.eu
Page 2 - Wacker Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wacker Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wacker Biotech Today - Breaking & Trending Today
WACKER To Start Construction Of Competence Center For mRNA Actives At Halle Site
The excavators are set to roll onto the WACKER site in Halle. As announced by the company today, the development of the Biotech site into an mRNA...
Source: pharmaceuticalonline.com
Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle
/PRNewswire/ -- Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA...
Source: prnewswire.com
Actym Therapeutics and Wacker Biotech Sign Biomanufacturing Contract
Wacker Biotech will begin GMP production of Phase I clinical material of Actym’s therapeutic candidate at its site in Amsterdam using its LIBATEC® technology. Both companies have already been working on technology transfer and initiation of scale-up production of ACTM-838, which is Actym’s lead clinical development candidate for solid tumor therapy and is on the company's immunotherapy platform called STACT.
Source: genengnews.com
Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym's Lead Candidate for the Treatment of Solid Tumors
BERKELEY, Calif. and AMSTERDAM, Feb. 28, 2022 /PRNewswire/ -- Actym Therapeutics, a biotechnology company focused on the discovery and development...
Source: businessinsider.com